Eupraxia Pharmaceuticals Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -0.02B-0.03B-0.03B
Depreciation and Depletion 0.00B0.00B0.00B
Share-based Compensation 0.00B0.00B0.00B
Gains from Investment Securities 0.00B0.00B
Cash from Operations -0.01B-0.02B-0.03B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.00B0.00B0.00B
Change in Working Capital
Change in Receivables -0.00B0.00B0.00B
Change in Accured Expenses 0.00B0.00B-0.00B
Other Working Capital Changes 0.00B0.00B0.00B
Investing Activities
Capital Expenditures 0.00B0.00B0.00B
Sales of Property, Plant and Equipment 0.00B0.00B
Change in Acquisitions & Divestments 0.01B
Cash from Investing Activities 0.01B-0.00B-0.00B
Financing Activities
Cash from Financing Activities 0.01B0.02B0.05B
Debt Issuance and Repayment
Net Debt Issuances and Repayments 33101.29B
Additional items
Exchange Rate Effect -0.00B0.00B-0.00B
Change in Cash 0.01B0.00B0.02B
Free Cash Flow -0.01B-0.02B-0.03B
Net Cash Flow 0.01B0.00B0.02B